Doximity, Inc. Class A (DOCS) Covered Calls
Doximity, Inc. is the leading digital platform for medical professionals in the United States. The company provides a secure, HIPAA-compliant network that enables physicians and clinicians to collaborate, stay current with medical news, and manage patient care. Through its unified suite of digital workflow tools, including telehealth and AI-powered documentation, Doximity helps healthcare professionals improve productivity and deliver more efficient care across the medical ecosystem.
You can sell covered calls on Doximity, Inc. Class A to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for DOCS (prices last updated Mon 4:16 PM ET):
| Doximity, Inc. Class A (DOCS) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 25.49 | +0.15 | 24.97 | 26.04 | 2.0M | 21 | 4.7 |
| Covered Calls For Doximity, Inc. Class A (DOCS) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Mar 20 | 25 | 1.30 | 24.74 | 1.1% | 33.5% | |
| Apr 17 | 25 | 2.05 | 23.99 | 4.2% | 38.3% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Doximity, Inc. (DOCS) operates the premier professional medical network in the U.S., reaching over 85% of physicians and two-thirds of nurse practitioners and physician assistants. Headquartered in San Francisco, the company provides a comprehensive digital ecosystem designed to streamline the professional lives of healthcare providers. Its business model is primarily subscription-based, with revenue generated from pharmaceutical companies and health systems that utilize the platform for targeted marketing, talent acquisition, and enterprise-level clinical workflow integration.
The platform’s core value lies in its high-utility workflow tools. Doximity Dialer has consistently been ranked as a top telehealth solution, facilitating hundreds of thousands of virtual patient visits daily. In early 2026, the company significantly advanced its technological lead by integrating the Pathway AI corpus into its DocsGPT suite. This allows clinicians to access peer-reviewed, evidence-based answers and automate administrative tasks like drafting clinical appeals or summarizing complex faxes. By early 2026, more than 100 health systems had already purchased enterprise access to these secure AI tools, covering over 180,000 prescribers.
Competitive Landscape
The competitive landscape for Doximity involves a mix of legacy telehealth providers and specialized healthcare technology firms. Primary rivals that are publicly traded on the NYSE or NASDAQ and offer active options markets include Teladoc Health, Inc. and Phreesia, Inc.. These companies compete for dominance in the digital health and patient engagement sectors.
Other notable competitors in the broader medical information and digital services space with active options trading include Veeva Systems Inc. and GoodRx Holdings, Inc.. While LinkedIn serves as a general professional network, Doximity distinguishes itself through its verified, physician-only community and HIPAA-compliant architecture. This specialized focus has allowed the company to maintain high net revenue retention, particularly among its top 20 pharmaceutical clients who utilize the platform’s high-engagement newsfeed to reach medical decision-makers.
Strategic Outlook
Strategic innovation is currently focused on the commercialization of "Agentic AI" to alleviate provider burnout. By early 2026, the company has deployed a new AI Scribe tool that features a 75% weekly retention rate, signaling its success as a "sticky" workflow integrated directly into the point of care. These investments in AI infrastructure are intended to offset slowing growth in legacy digital advertising by opening new revenue streams through enterprise software licenses for health systems looking to standardize their AI-assisted clinical workflows.
The outlook involves a disciplined capital allocation strategy, highlighted by a $500 million share repurchase program authorized in February 2026. Management is prioritizing margin stability, aiming to maintain adjusted EBITDA margins near 55% despite increased spending on AI compute and infrastructure. By leveraging its dominant market share and expanding its self-service portal for smaller agencies, Doximity aims to navigate policy-driven shifts in pharmaceutical marketing budgets while solidifying its role as the essential operating system for the modern U.S. physician.
| Top 10 Open Interest For Mar 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | QQQ covered calls | 1. | CTMX covered calls | |
| 2. | SLV covered calls | 7. | EWZ covered calls | 2. | PATH covered calls | |
| 3. | EEM covered calls | 8. | GLD covered calls | 3. | KSS covered calls | |
| 4. | SPY covered calls | 9. | FXI covered calls | 4. | OWL covered calls | |
| 5. | IBIT covered calls | 10. | KWEB covered calls | 5. | USO covered calls | |
Want more examples? DOCN Covered Calls | DOCU Covered Calls
Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.
Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.
No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.
You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.
